Crexendo (EXE)

Add to Watchlists Create an Alert
2.67 -0.14  -4.98%   AMEX May 22, 8:00PM BATS Real time Currency in USD

Crexendo R&D Expense Quarterly:

0.481M for March 31, 2013
View Full Chart

Crexendo R&D Expense Quarterly Chart

    Crexendo Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 0.481M
    Dec. 31, 2012 0.466M
    Sept. 30, 2012 0.42M
    June 30, 2012 0.505M
    March 31, 2012 0.594M
    Dec. 31, 2011 0.712M
    Sept. 30, 2011 0.807M
    June 30, 2011 0.871M
    March 31, 2011 0.872M
    Dec. 31, 2010 0.88M
    Sept. 30, 2010 0.957M
    June 30, 2010 0.715M
    March 31, 2010 0.538M
    Sept. 30, 2009 0.503M
    June 30, 2009 0.582M
    March 31, 2009 0.515M
    Dec. 31, 2008 0.497M
    Sept. 30, 2008 0.583M
    June 30, 2008 0.533M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
       
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro
    Sept. 30, 2000 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    EXE R&D Expense Quarterly Benchmarks

    Companies
    Accelrys 10.37M
    Mobile Star 0.00
    Rally Software Development 4.424M

    EXE R&D Expense Quarterly Rankings

    Overall 82nd percentile
    1404 of 8006
    Sector 36th percentile
    605 of 952 in Technology
    Industry 34th percentile
    129 of 196 in Software - Application

    EXE R&D Expense Quarterly Range, Past 5 Years

    Minimum 0.4200M Sep 2012
    Maximum 0.9570M Sep 2010
    Average 0.6332M